CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


07-February-2017
Cerilliant, now a part of MilliporeSigma, introduces its latest pharmaceutical drug metabolite solution CRMs - (±)-Norverapamil HCl & 8-Hydroxy Amoxapine.

8-Hydroxy Amoxapine, 1.0 mg/mL H-118-1ML
1.0 mg/mL in Methanol

A major, active metabolite of the tetracyclic antidepressant amoxapine. Amoxopine is sold under trade names including Asendin®, Asendis®, Defanyl® and Demolox® for the treatment of major depressive disorder. This Certified Snap-N-Spike® Solution is suitable for use in chromatographic or mass spectrometry testing applications for clinical toxicology, forensic analysis, urine drug testing, pharmaceutical research, or therapeutic drug monitoring.

(±)-Norverapamil HCl,1.0 mg/mL N-112
1.0 mg/mL (as free base) in Methanol

Norverapamil is a primary urinary metabolite of verapamil, a calcium channel blocker used in the treatment of hypertension, angina pectoris, and cardiac arrhythmia. Verapamil is also an effective preventive medication for migraines. This Certified Reference Material is applicable for use as starting material in calibrators or controls for verapamil testing methods by LC-MS/MS or GC-MS.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn